Reactive oxygen species induction by cabazitaxel through inhibiting Sestrin-3 in castration resistant prostate cancer

Takeo Kosaka; Hiroshi Hongo; Yasumasa Miyazaki; Koshiro Nishimoto; Akira Miyajima; Mototsugu Oya

doi:10.18632/oncotarget.21147

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Reactive oxygen species induction by cabazitaxel through inhibiting Sestrin-3 in castration resistant prostate cancer

Takeo Kosaka _, Hiroshi Hongo, Yasumasa Miyazaki, Koshiro Nishimoto, Akira Miyajima and Mototsugu Oya

PDF | HTML | How to cite

Oncotarget. 2017; 8:87675-87683. https://doi.org/10.18632/oncotarget.21147

Metrics: PDF 1350 views | HTML 2195 views | ?

Abstract

Takeo Kosaka1, Hiroshi Hongo1, Yasumasa Miyazaki1, Koshiro Nishimoto2, Akira Miyajima3 and Mototsugu Oya1

1Department of Urology, Keio University School of Medicine, Tokyo, Japan

2Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka, Japan

3Department of Urology, Tokai University School of Medicine, Hiratsuka-shi, Japan

Correspondence to:

Takeo Kosaka, email: [email protected]

Keywords: castration-resistant prostate cancer, cabazitaxel, ROS, SESN3

Received: April 04, 2017 Accepted: August 23, 2017 Published: September 21, 2017

ABSTRACT

Reactive oxygen species (ROS) production induced by taxanes in cancer cells may influence the taxane-induced cell death or the drug resistance. We investigated the correlation between the cytotoxic effect of taxanes and ROS production in human castration-resistant prostate cancer (CRPC) cell lines. Three human prostate cancer cell lines were treated with increasing concentrations of docetaxel or cabazitaxel in vitro. Cabazitaxel showed significantly higher cytotoxic efficacy than docetaxel in human CRPC cells, accompanied by elevated ROS production detected by FACS analysis. To investigate whether cabazitaxel-mediated cell death was caused by the ROS generation induced by cabazitaxel, we treated CRPC cells in the presence of antioxidant NAC. NAC reduced the cytotoxic effect induced by cabazitaxel. We found that ROS elimination by Sestrin-3 (SESN3) was significantly inhibited by cabazitaxel, but not by docetaxel. These results indicate higher sensitivity of human CRPC to cabazitaxel compared to docetaxel involves ROS production through inhibiting the expression of antioxidant enzyme SESN3.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21147

Publication Alerts

Research Papers:

Reactive oxygen species induction by cabazitaxel through inhibiting Sestrin-3 in castration resistant prostate cancer

Abstract